Novel therapeutic targets in non-small cell lung cancer

scientific article published on September 2011

Novel therapeutic targets in non-small cell lung cancer is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1097/JTO.0B013E31822944B3
P698PubMed publication ID21849857

P50authorRazelle KurzrockQ56614941
Ignacio Garrido-LagunaQ71791712
Filip JankuQ73569186
P2093author name stringDavid J Stewart
Lubos B Petruzelka
P2860cites workMET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingQ27851406
Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.Q45950196
P433issue9
P921main subjectlung cancerQ47912
P304page(s)1601-1612
P577publication date2011-09-01
P1433published inJournal of Thoracic OncologyQ2448056
P1476titleNovel therapeutic targets in non-small cell lung cancer
P478volume6